Investor profile
IP Group has backed 23 European tech companies across 27 funding rounds between 2018 and 2026, joining rounds totalling €801M. Most active in Healthtech and Software. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Oxford Nanopore Technologies | UK | 1 | €225M |
| Ultraleap | UK | 1 | €72M |
| Microbiotica | UK | 1 | €61M |
| Quantum Motion | UK | 1 | €48M |
| Ieso | UK |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Oxford Nanopore Technologies | Other | €225M | 2021-05 |
| Ultraleap | Series D+ | €72M | 2021-11 |
| Microbiotica | Series B | €61M | 2022-03 |
| Quantum Motion |
| 1 |
| €47M |
| Bramble Energy | UK | 1 | €42M |
| moa Technology Limited | UK | 1 | €41M |
| First Light Fusion | UK | 1 | €40M |
| AccelerComm | UK | 2 | €38M |
| Mantle8 | France | 1 | €31M |
| Enterprise Therapeutics | UK | 1 | €30M |
| Oxbotica | UK | 1 | €16M |
| Slamcore | UK | 1 | €15M |
| Alesi Surgical | Ireland | 2 | €14M |
| DiffBlue | UK | 2 | €14M |
| MISSION Therapeutics | UK | 1 | €11M |
| Barocal | UK | 2 | €10M |
| GripAble | UK | 1 | €10M |
| Lumai | UK | 1 | €9.3M |
| Vytal | Germany | 1 | €9.1M |
| Deep Render | UK | 1 | €8.3M |
| Intrinsic | UK | 1 | €7.9M |
| Arkivum | UK | 1 | €1.7M |
| Series B |
| €48M |
| 2023-02 |
| Ieso | Series B | €47M | 2021-11 |
| Bramble Energy | Other | €42M | 2022-02 |
| moa Technology Limited | Series B | €41M | 2022-06 |
| First Light Fusion | Series C | €40M | 2022-02 |
| Mantle8 | Series A | €31M | 2026-05 |
| Enterprise Therapeutics | Series B | €30M | 2024-01 |
